FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
We are very excited to launch our new website! Please take a few moments to click around and explore...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...